Nuwellis Reports Preliminary Q2 Revenue Growth of 14%
Nuwellis (NUWE) reported preliminary, unaudited revenue results for the second quarter ended June 30, 2026. The company saw a year-over-year growth rate of 14% in Q2 and achieved a cumulative increase of 20% over the first six months of 2026. CEO Mike McCormick attributed this performance to growing adoption of Nuwellis' Aquadex system and progress toward long-term strategic goals. The results highlight continued momentum for the company, particularly as it expands its market presence through product innovation like recent U.S. patent approvals. The growth trajectory suggests that Nuwellis is gaining traction in key markets despite broader economic uncertainties affecting healthcare sectors.
